EXPERIENCE OF USE OF DTAP HEXAVACCINE AT THE VACCINAL PREVENTION UNIT FOR CHILDREN WITH HEALTH DEVIATIONS OF THE SCIENTIFIC CENTER OF CHILDREN’S HEALTH (FEDERAL STATE BUDGETARY SCIENTIFIC INSTITUTION)
Nowadays, parents are anxious about vaccination, as they fear both side effects of vaccines and large numbers of injections. The need in simultaneous administration of 4–5 injections became irrelevant due to development of combined vaccines; it resulted in improved vaccination coverage of children a...
Main Authors: | T. A. Grechukha, N. E. Tkachenko, D. A. Novikova, G. A. Gaivoronskaya, L. S. Namazova-Baranova |
---|---|
Format: | Article |
Language: | English |
Published: |
Paediatrician Publishers, LLC
2014-07-01
|
Series: | Pediatričeskaâ Farmakologiâ |
Subjects: | |
Online Access: | https://www.pedpharma.ru/jour/article/view/70 |
Similar Items
-
The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019-09-01) -
RESULTS OF A MULTICENTER CLINICAL STUDY OF A NEW COMBINATION VACCINE DTaP-HepB+Hib PRODUCTION OF THE CPA «MICROGEN» FOR IMMUNIZATION OF CHILDREN 6 MONTHS
by: I. V. Feldblyum, et al.
Published: (2018-04-01) -
Safety of pentavalent DTaP-IPV/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017
by: Zhiqun Li, et al.
Published: (2020-10-01) -
Genetic Variation in the Magnitude and Longevity of the IgG Subclass Response to a Diphtheria-Tetanus-Acellular Pertussis (DTaP) Vaccine in Mice
by: Yung-Yi C. Mosley, et al.
Published: (2019-09-01) -
PHARMACOECONOMIC ANALYSIS OF USE OF PENTAVALENT COMBINATION VACCINE WITH ACELLULAR PERTUSSIS COMPONENT IN THE FRAMEWORK OF THE REGIONAL IMMUNIZATION SCHEDULE OF KRASNODAR FOR ALL CHILDREN AGED 0–18 MONTHS AND SEPARATLY FOR CHILDREN AT RISK
by: A. Yu. Kulikov, et al.
Published: (2014-11-01)